(RTTNews) - Sandoz said it has entered into an agreement to acquire worldwide product rights for systemic antifungal agent Mycamine from Astellas Pharma Inc. (ALPMY, ALPMY). Closing is anticipated ...

Swiss drugmaker Sandoz said on Saturday it had launched a biosimilar version of AbbVie Inc's big selling arthritis treatment Humira, adding to U.S. competition for the drug that started in January.

ZURICH, Sept 25 (Reuters) - Novartis (NOVN.S), opens new tab on Monday confirmed its plans for a 100% spin-off of the Sandoz business on Oct. 4 after shareholders gave their approval earlier this ...